Standout Papers

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection 1994 2026 2004 2015 3.3k
  1. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection (1995)
    David D. Ho, Avidan U. Neumann et al. Nature
  2. HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time (1996)
    Alan S. Perelson, Avidan U. Neumann et al. Science
  3. Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy (1997)
    Diana Finzi, Monika Hermankova et al. Science
  4. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome (1994)
    Richard A. Koup, Jeffrey T. Safrit et al. Journal of Virology
  5. Decay characteristics of HIV-1-infected compartments during combination therapy (1997)
    Alan S. Perelson, Mika Vesanen et al. Nature
  6. Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA (1998)
    Graham S. Ogg, Xia Jin et al. Science
  7. Dramatic Rise in Plasma Viremia after CD8+ T Cell Depletion in Simian Immunodeficiency Virus–infected Macaques (1999)
    Xia Jin, Daniel Bauer et al. The Journal of Experimental Medicine
  8. The role of a mutant CCR5 allele in HIV–1 transmission and disease progression (1996)
    Yaoxing Huang, William A. Paxton et al. Nature Medicine
  9. Genotypic and Phenotypic Characterization of HIV-1 Patients with Primary Infection (1993)
    Tuofu Zhu, Hongmei Mo et al. Science
  10. Efficient Neutralization of Primary Isolates of HIV-1 by a Recombinant Human Monoclonal Antibody (1994)
    Dennis R. Burton, Jayashree Pyati et al. Science
  11. Identification of microRNAs of the herpesvirus family (2005)
    Sébastien Pfeffer, Alain Sewer et al. Nature Methods
  12. Quantitation of Human Immunodeficiency Virus Type 1 in the Blood of Infected Persons (1989)
    David D. Ho, Tarsem Moudgil et al. New England Journal of Medicine
  13. Isolation of HTLV-III from Cerebrospinal Fluid and Neural Tissues of Patients with Neurologic Syndromes Related to the Acquired Immunodeficiency Syndrome (1985)
    David D. Ho, T R Rota et al. New England Journal of Medicine
  14. Virologic and Immunologic Characterization of Long-Term Survivors of Human Immunodeficiency Virus Type 1 Infection (1995)
    Yunzhen Cao, Linqi Zhang et al. New England Journal of Medicine
  15. Recognition of bacterial glycosphingolipids by natural killer T cells (2005)
    Yuki Kinjo, Douglass Wu et al. Nature
  16. Quantifying Residual HIV-1 Replication in Patients Receiving Combination Antiretroviral Therapy (1999)
    Linqi Zhang, Bharat Ramratnam et al. New England Journal of Medicine
  17. Transient High Levels of Viremia in Patients with Primary Human Immunodeficiency Virus Type 1 Infection (1991)
    Eric S. Daar, Tarsem Moudgil et al. New England Journal of Medicine
  18. Ordered accumulation of mutations in HIV protease confers resistance to ritonavir (1996)
    Akhteruzzaman Molla, Marina Korneyeva et al. Nature Medicine
  19. Infection of monocyte/macrophages by human T lymphotropic virus type III. (1986)
    David D. Ho, T R Rota et al. Journal of Clinical Investigation
  20. Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding (1993)
    Markus Thali, John P. Moore et al. Journal of Virology
  21. Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants (2022)
    Qian Wang, Sho Iketani et al. Cell
  22. Antibody evasion properties of SARS-CoV-2 Omicron sublineages (2022)
    Sho Iketani, Lihong Liu et al. Nature
  23. Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5 (2022)
    Qian Wang, Yicheng Guo et al. Nature
  24. Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization (2021)
    Pengfei Wang, Ryan G. Casner et al. Cell Host & Microbe
  25. Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir (2022)
    Sho Iketani, Hiroshi Mohri et al. Nature
  26. Antigenicity and receptor affinity of SARS-CoV-2 BA.2.86 spike (2023)
    Qian Wang, Yicheng Guo et al. Nature
  27. A pseudovirus system enables deep mutational scanning of the full SARS-CoV-2 spike (2023)
    Bernadeta Dadonaite, Katharine H. D. Crawford et al. Cell
  28. XBB.1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against XBB subvariants and JN.1 (2024)
    Qian Wang, Yicheng Guo et al. Cell Host & Microbe

Immediate Impact

44 by Nobel laureates 201 from Science/Nature 270 standout
Sub-graph 1 of 12

Citing Papers

Completion of the entire hepatitis C virus life cycle in genetically humanized mice
2013 StandoutNatureNobel
A dicer-independent miRNA biogenesis pathway that requires Ago catalysis
2010 StandoutNature
10 intermediate papers

Works of David D. Ho being referenced

Identification of microRNAs of the herpesvirus family
2005 StandoutNobel
Efficient Neutralization of Primary Isolates of HIV-1 by a Recombinant Human Monoclonal Antibody
1994 StandoutScience
and 5 more

Author Peers

Author Last Decade Papers Cites
David D. Ho 37901 27071 19019 347 53.4k
Beatrice H. Hahn 29579 17906 15047 409 43.9k
Douglas D. Richman 39017 37026 10144 506 55.1k
Bruce D. Walker 32208 15120 27257 578 51.4k
George M. Shaw 24808 14049 11735 231 31.7k
Robert C. Gallo 29146 18284 34821 693 76.1k
Richard A. Koup 22637 13663 24200 307 42.0k
Joseph Sodroski 42324 18890 27384 445 55.8k
Robert F. Siliciano 25789 16908 11416 306 30.9k
Daniel C. Douek 18754 10802 26226 333 44.0k
John P. Moore 29936 14009 16669 367 37.0k

All Works

Loading papers...

Rankless by CCL
2026